SNSS insider transactions
Sunesis Pharmaceuticals, Inc. (SNSS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
SNSS insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Sunesis Pharmaceuticals, Inc., latest first. Follow anyone to get their next filing.
- Barry J. SimonDirector, since March 2021
- Stephen RubinoDirector, since March 2021
- aMoon Growth Fund Limited Partnership10% owner, since February 2021
- Gur RoshwalbDirector, 10% owner, since February 2021
- Daniel R. ChevallardOfficer, since February 2021
- Thomas E DarcyDirector, since February 2021
- Michael HuangDirector, since February 2021
- Samuel Lafayette MurphyDirector, since February 2021
- Roger PomerantzDirector, since February 2021
- Lisa RojkjaerOfficer, since February 2021
- Ivor RoystonOfficer, Director, since February 2021
Recent Form 3, 4, and 5 filings for SNSS
- SEC Form 3 filed by J. Barry Simon3 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
- SEC Form 3 filed by Stephen Rubino3 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
- SEC Form 3: Partnership Limited Fund 2 Amoon claimed ownership of 7,392,237 units of Common Stock3 - SUNESIS PHARMACEUTICALS INC (0001061027) (Issuer)
- SEC Form 3: Gur Roshwalb claimed ownership of 7,392,237 units of Common Stock3 - SUNESIS PHARMACEUTICALS INC (0001061027) (Issuer)
- SEC Form 3: R. Daniel Chevallard claimed ownership of 44,760 units of Common Stock3 - SUNESIS PHARMACEUTICALS INC (0001061027) (Issuer)
- SEC Form 3 filed by E Thomas Darcy3 - SUNESIS PHARMACEUTICALS INC (0001061027) (Issuer)
- SEC Form 3 filed by Michael Huang3 - SUNESIS PHARMACEUTICALS INC (0001061027) (Issuer)
- SEC Form 3 filed by Lafayette Samuel Murphy3 - SUNESIS PHARMACEUTICALS INC (0001061027) (Issuer)
- SEC Form 3 filed by Roger Pomerantz3 - SUNESIS PHARMACEUTICALS INC (0001061027) (Issuer)
- SEC Form 3 filed by Lisa Rojkjaer3 - SUNESIS PHARMACEUTICALS INC (0001061027) (Issuer)
- SEC Form 3: Ivor Royston claimed ownership of 559,198 units of Common Stock3 - SUNESIS PHARMACEUTICALS INC (0001061027) (Issuer)